Sen, S., Carneiro, B. A., Wang, J. S., Koganemaru, S., Kitano, S., Yoshizuka, N., Mizuno, S., Rajper, A. W., Li, A., Tolcher, A. W. (2026). A phase 1, first-in-human study of DS5361, a small-molecule, nonsense-mediated mRNA decay (NMD) inhibitor in patients with advanced/metastatic solid tumors (parts 1 and 2).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2680